Check sentinel lymph node biopsy for several eye skin cancers
Part of Cancer, Infections clinical trials.
This trial studies whether a “sentinel lymph node biopsy” can better detect cancer spread in people with specific cancers of the eye surface and nearby tissues. It may help doctors find the right next treatment by learning whether lymph nodes are involved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have one of these specific cancers: porocarcinoma, Merkel cell cancer, sebaceous cancer
- Have a qualifying eyelid/eye-skin cancer type (including certain conjunctival or surface cancers) with required stage or growth features
- Have no known metastatic cancer (spread to distant parts of the body) at the time of enrollment
- Be able to sign informed consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at skin growths near the eye using a special camera. It may help doctors better understand and diagnose these growths without needing a biopsy.
This trial studies whether very small deposits of cancer (called micrometastasis or isolated tumor cells) are found in sentinel lymph nodes in early endometrial or cervical cancer. The goal is to better understand what these findings may mean for cancer spread and treatment planning.
This study checks whether a “sentinel lymph node biopsy” can help find if skin cancer in the head or neck has spread to nearby lymph nodes. It uses special dye/medicine and imaging, then removes the cancer and the sentinel node soon after scanning.
This study uses a test to see if a type of skin cancer called high-risk cutaneous squamous cell carcinoma has spread to lymph nodes. The goal is to learn more about how to detect spread early, which could help guide treatment decisions.
This trial compares two ways of checking whether early oral cavity squamous cell cancer has spread to neck lymph nodes. It tests whether sentinel lymph node biopsy can find spread as well as standard neck dissection, while potentially reducing more extensive surgery for some people.
This trial tests two drugs, sintilimab and disitamab vedotin, for a rare type of eyelid cancer called sebaceous gland carcinoma. The goal is to see if this combination can shrink or control the cancer before surgery, potentially making it easier to remove.
Hear when a new Ocular Sebaceous Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.